Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Tohoku Journal of Experimental Medicine|August 7, 2004
Development and construct validation of the Korean competence scale (KCS)Chang-Wan Han, Yuki Yajima, Eun-Joo Lee, et al.
Heliyon|October 9, 2023
SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunityYuki Yajima, Akemi Kosaka, Takayuki Ohkuri, et al.
Endocrine Journal|April 8, 2010
Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitisMichiko Hori, Noriko Makita, Takahiro Andoh, et al.
Endocrine Research|October 21, 2010
The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinolJun Saito, Yoko Matsuzawa, Hiroko Ito, et al.
Glycobiology|December 31, 2004
Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide libraryYumi Ito, Megumi Hikino, Yuki Yajima, et al.
Diabetes Research and Clinical Practice|February 12, 2008
Social support, self-efficacy and psychological stress responses among outpatients with diabetes in Yogyakarta, IndonesiaSakiko Kanbara, Hiroshi Taniguchi, Motoyoshi Sakaue, et al.
The Journal of Biological Chemistry|September 8, 2016
Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R AgonistNoriko Makita, Tomohiko Sato, Yuki Yajima-Shoji, et al.
Biochemical and Biophysical Research Communications|November 28, 2019
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinomaShohei Harabuchi, Akemi Kosaka, Yuki Yajima, et al.
Cancer Science|May 17, 2022
A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicityYuki Yajima, Akemi Kosaka, Kei Ishibashi, et al.
Immunological Medicine|January 18, 2024
NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike proteinAiko Murai, Terufumi Kubo, Takayuki Ohkuri, et al.
Pageof 3